正海生物 (300653.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(正海生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2019年第三季度2019年第二季度2019年第一季度2018年第四季度2018年第三季度2018年第二季度2018年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 68,635,336.7371,225,324.0861,416,170.7650,073,908.9860,272,347.6658,017,802.1047,179,561.64
 营业收入(元) 68,635,336.7371,225,324.0861,416,170.7650,073,908.9860,272,347.6658,017,802.1047,179,561.64
二、营业总成本(元) 39,633,311.8947,616,103.3733,417,994.0634,358,070.3933,817,923.6239,829,126.6525,428,114.29
 营业成本(元) 3,350,246.075,382,536.363,780,097.333,056,999.103,912,344.794,508,908.493,442,338.43
 研发费用(元) 5,332,191.625,641,254.634,078,356.964,420,212.803,591,733.08--
 营业税金及附加(元) 477,674.83484,955.06445,700.31564,000.31603,647.09521,880.87422,722.99
 销售费用(元) 26,501,572.4531,837,349.0620,893,715.6822,033,954.7721,722,784.8324,221,097.3515,591,137.87
 管理费用(元) 4,139,221.154,621,025.614,428,271.004,346,423.474,239,367.1510,338,326.696,234,017.48
 财务费用(元) -200,063.65-254,308.74-308,803.08-235,804.72-340,486.37-220,137.30-230,441.67
  其中:利息费用(元) ------
  其中:利息收入(元) 260,576.11313,548.501,838,261.08-343,469.17--
 资产减值损失(元) ---172,284.6688,533.05459,050.55-31,660.81
 信用减值损失(元) -96,708.61100,655.86----
三、其他经营收益
 加:投资收益(元) 3,449,552.002,973,229.963,262,218.875,199,626.952,812,312.612,804,261.063,666,202.72
 净敞口套期收益(元) ------
 资产处置收益(元) ------
 其他收益(元) 1,371,311.30449,403.641,505,890.31484,020.90346,484.64482,565.02
四、营业利润(元) 33,706,593.0027,952,662.5631,709,799.2122,386,507.2329,750,757.5521,339,421.1525,900,215.09
 加:营业外收入(元) 78,621.3539,798.00205,057.0127,093.18133,191.8250,130.004,200.00
 减:营业外支出(元) 22,402.8440,511.1711,845.02-11,308.5735,460.5637,141.2185,061.99
五、利润总额(元) 33,762,811.5127,951,949.3931,903,011.2022,424,908.9829,848,488.8121,352,409.9425,819,353.10
 减:所得税费用(元) 5,141,182.394,008,987.424,855,301.881,762,182.954,673,412.273,258,067.753,936,430.38
六、净利润(元) 28,621,629.1223,942,961.9727,047,709.3220,662,726.0325,175,076.5418,094,342.1921,882,922.72
(一)按经营持续性分类
  持续经营净利润(元) 23,942,961.9727,047,709.3220,662,726.0325,175,076.5418,094,342.1921,882,922.72
  终止经营净利润(元) ------
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 28,621,629.1223,942,961.9727,047,709.3220,662,726.0325,175,076.5418,094,342.1921,882,922.72
 扣除非经常性损益后的净利润(元) 27,505,908.0422,775,281.9526,499,864.4319,382,577.4924,678,152.6717,787,618.1721,537,048.54
七、每股收益
 一、基本每股收益(元) 0.360.300.340.260.310.230.27
 二、稀释每股收益(元) 0.360.300.340.260.310.230.27
九、综合收益总额(元) 28,621,629.1223,942,961.9727,047,709.3220,662,726.0325,175,076.5418,094,342.1921,882,922.72
 归属于母公司所有者的综合收益总额(元) 28,621,629.1223,942,961.9727,047,709.3220,662,726.0325,175,076.5418,094,342.1921,882,922.72
公告日期 2019-10-242019-08-222019-04-262019-03-302018-10-202018-08-102018-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院